Glaukos Corp at JPMorgan Healthcare Conference Transcript
Okay. I want to thank everyone for being here in the last session today on Tuesday. My name is Allen Gong. I'm on the medical supplies and devices team here at JPMorgan. I'm really excited to be introducing members of the Glaukos management team and especially Tom Burns, who will be kicking us off with some prepared remarks before we bring on more members for the Q&A. All yours.
Thank you. Well, good evening, and thank you for joining us this evening, and I'm happy to give you an update on the progress that we're making at Glaukos. From the inception of our business, our mission has been to transform glaucoma therapy, but our aspirations have always been higher.
And so today, we seek to elevate the standard of care across 3 major therapeutic areas, glaucoma, corneal health and retinal disease. Innovation is at the core of everything we do here at Glaukos. And we've taken on this mantra of the company of "We'll Go First".
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |